Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Liabilities ₹1,026 Cr₹880 Cr₹793 Cr₹739 Cr₹157 Cr

What is the latest Total Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Liabilities ratio of NATH BIOGENES (INDIA) is ₹1,026 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹1,026 Cr
Mar2024₹880 Cr
Mar2023₹793 Cr
Mar2022₹739 Cr
Mar2013₹157 Cr

How is Total Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Liabilities % Change
Mar2025 ₹1,026 Cr
16.58
Mar2024 ₹880 Cr
11.03
Mar2023 ₹793 Cr
7.21
Mar2022 ₹739 Cr
369.87
Mar2013 ₹157 Cr -

Compare Total Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹315.4 Cr -1.8% -3.1% -8.5% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,850.9 Cr -3.3% -3.3% -33% Stock Analytics
KAVERI SEED COMPANY ₹5,500.4 Cr 9.8% 0.9% 16.2% Stock Analytics
VENKYS (INDIA) ₹1,906.4 Cr 1.3% -7.7% -22.3% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,219.6 Cr -3.6% -6% -26.6% Stock Analytics
INDO US BIOTECH ₹248.4 Cr -5.7% -4.3% -47.4% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-1.8%

-3.1%

-8.5%

SENSEX

1.7%

3.6%

6.9%


You may also like the below Video Courses